Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q96S37: Variant p.Arg477His

Solute carrier family 22 member 12
Gene: SLC22A12
Feedback?
Variant information Variant position: help 477 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Arginine (R) to Histidine (H) at position 477 (R477H, p.Arg477His). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and basic (R) to medium size and polar (H) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In RHUC1. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 477 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 553 The length of the canonical sequence.
Location on the sequence: help SELFPTVLRMTAVGLGQMAA R GGAILGPLVRLLGVHGPWLP The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         SELFPTVLRMTAVGLGQMAARGGAILGPLVRLLGVHGPWLP

Mouse                         SELFPTVIRMTAVGLCQVAARGGAMLGPLVRLLGVYGSWMP

Rat                           SELFPTVIRMTAVGLGQVAARGGAMLGPLVRLLGVYGSWLP
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 553 Solute carrier family 22 member 12
Transmembrane 466 – 486 Helical



Literature citations
A high prevalence of renal hypouricemia caused by inactive SLC22A12 in Japanese.
Iwai N.; Mino Y.; Hosoyamada M.; Tago N.; Kokubo Y.; Endou H.;
Kidney Int. 66:935-944(2004)
Cited for: VARIANTS RHUC1 HIS-90; 313-ASP--PRO-333 DEL AND HIS-477; VARIANTS VAL-226 AND LEU-312; CHARACTERIZATION OF VARIANT RHUC1 313-ASP--PRO-333 DEL; Mutational analysis of idiopathic renal hypouricemia in Korea.
Cheong H.I.; Kang J.H.; Lee J.H.; Ha I.S.; Kim S.; Komoda F.; Sekine T.; Igarashi T.; Choi Y.;
Pediatr. Nephrol. 20:886-890(2005)
Cited for: VARIANTS RHUC1 HIS-90 AND HIS-477; Hereditary renal hypouricemia type 1 and autosomal dominant polycystic kidney disease.
Stiburkova B.; Stekrova J.; Nakamura M.; Ichida K.;
Am. J. Med. Sci. 350:268-271(2015)
Cited for: VARIANTS RHUC1 ARG-366 AND HIS-477; CHARACTERIZATION OF VARIANT RHUC1 ARG-366;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.